View |
|
DR-XY14899
|
Aluminum Hychloride Hexahydrate
|
Driclor
|
185 mg/mL
|
Solution
|
-
|
Stiefel Laboratories (Ireland) Ltd.
|
Ireland
|
-
|
23 October 2020
|
03 October 2025
|
View |
|
DR-XY14900
|
Potassium Chloride
|
None
|
14.90%
|
Solution For Iv Infusion
|
-
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
-
|
30 September 2019
|
09 February 2025
|
View |
|
DR-XY14904
|
Balanced Multiple Maintenance Solution/5% Dextrose
|
Plasma-Lyte 56
|
Each 100mL contains: Dextrose Hydrous Potassium Acetate Magnesium Acetate Tetrahydrate Sodium Chloride
5 mg 128 mg
32 mg 234 mg
|
Solution for IV Infusion
|
-
|
Baxter Healthcare Philippines Inc.
|
Philippines
|
-
|
10 November 2021
|
20 July 2025
|
View |
|
DR-XY14916
|
Loperamide Hydrochloride
|
Imodium
|
2 mg
|
Capsule
|
Antimotility
|
Interphil Laboratories
|
Philippines
|
Automatic Renewal
|
05 January 2023
|
07 July 2028
|
View |
|
DR-XY14979
|
Cefalexin (as monohydrate)
|
Zeporin
|
250mg/5mL
|
Powder For Suspension
|
-
|
Drugmakers Laboratories, Inc.
|
Philippines
|
-
|
10 September 2021
|
03 February 2025
|
View |
|
DR-XY14983
|
Doxycycline (As Hydrochloride)
|
Doxicon
|
100 mg
|
Capsule
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
23 August 2019
|
15 July 2024
|
View |
|
DR-XY15001
|
Leuprorelin Acetate
|
Luprolex
|
3.75mg
|
Powder for Injection (IM/SC) [Sustained Release]
|
-
|
Takeda Pharmaceutical Co. Ltd.
|
Japan
|
-
|
29 December 2020
|
22 January 2026
|
View |
|
DR-XY15023
|
Salbutamol (as sulfate)
|
None
|
2 mg/5 mL
|
Syrup
|
Bronchodilator
|
Marnets Pharma Corporation
|
Philippines
|
Automatic Renewal
|
14 January 2022
|
15 October 2026
|
View |
|
DR-XY15068
|
Cotrimoxazole
|
Jestrim
|
200mg/40mg per 5mL
|
Suspension
|
-
|
Lloyd Laboratores, Inc.
|
Philippines
|
-
|
20 February 2020
|
01 February 2025
|
View |
|
DR-XY15092
|
Water For Injection
|
None
|
Not applicable
|
Not Applicable
|
-
|
B. Braun Medical Industries Sdn. Bhd.
|
Malaysia
|
-
|
21 February 2020
|
23 March 2025
|
View |
|
DR-XY15101
|
Balanced Multiple Maintenance Solution With 5% Dextrose
|
Euro-Ion In D5 Water
|
Each 100 mL contains 5 g Dextrose Monohydrate, 189 mg Sodium Acetate, Anhydrous, 141 mg Potassium Chloride, 21.4 mg Sodium Phosphate Monobasic, 30.5 mg Magnesium Chloride Hexahydrate, 15 mg Monopotassium Phosphate & 20 mg Sodium Metabisulfite
|
Solution for Intravenous Infusion
|
Parenteral Rehydration Solution
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
Automatic Renewal
|
18 April 2022
|
27 October 2027
|
View |
|
DR-XY15192
|
Amoxicillin (as trihydrate)
|
Rielmox
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories Inc.
|
Philippines
|
-
|
26 December 2019
|
29 December 2024
|
View |
DR-XY15245_PI_01.pdf
|
DR-XY15245
|
Zuclopenthixol acetate
|
Clopixol- Acuphase
|
50mg/Ml
|
Solution for Injection (IM)
|
Antipsychotic ( Neuroleptic)
|
H. Lundbeck A/S
|
Denmark
|
Renewal
|
17 January 2024
|
24 June 2029
|
View |
|
DR-XY15251
|
Salbutamol (As Sulfate)
|
Asfrenon
|
2 mg /5mL
|
Syrup
|
-
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
11 March 2020
|
04 February 2025
|
View |
|
DR-XY15253-B
|
Cefalexin (As Monohydrate)
|
Infexin
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
11 April 2022
|
02 May 2027
|
View |
|
DR-XY15290
|
Calcipotriol
|
Daivonex
|
50 mcg/g (0.005%)
|
Ointment
|
Antipsoriatics
|
Leo Laboratories Ltd.
|
Ireland
|
Automatic Renewal
|
19 September 2022
|
15 October 2027
|
View |
|
DR-XY15314-B
|
Cefalexin (As Monohydrate)
|
Infexin
|
125 mg/5 mL
|
Granules For Oral Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 April 2022
|
20 March 2027
|
View |
DR-XY15352_PI_01.pdf
|
DR-XY15352
|
Tobramycin + Dexamethason
|
Tobradex
|
3mg/ 1mg per g
|
Sterile Ophthalmic Ointment
|
Anti-infective
|
Alcon-Couvreur N.V.
|
Belgium
|
Automatic Renewal
|
29 March 2022
|
04 February 2027
|
View |
|
DR-XY15354
|
Isoniazid
|
None
|
100mg/5mL
|
Syrup
|
-
|
AM-Europharma
Corporation
|
Philippines
|
-
|
26 March 2020
|
21 June 2025
|
View |
|
DR-XY15378
|
Cefuroxime (as sodium)
|
Zinacef
|
750mg
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
GlaxoSmithKline Manufacturing S.P.A
|
Italy
|
Automatic Renewal
|
04 February 2020
|
10 February 2025
|